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Introduction
Renal and other solid organ transplant recipients are at a 
significantly increased risk of pulmonary and extra-pulmonary 
tuberculosis compared with the general population [1,2], particularly in 
the first year post-transplant. Diagnosis of post-transplant tuberculosis 
is a challenge, especially in the setting of extra-pulmonary disease. In 
the face of immunosuppression the disease may present with atypical 
or non-specific symptoms that can be attributed to other conditions. 
The absence of pathognomic features on imaging and frequently 
inconclusive histopathology findings can make the diagnosis difficult to 
make. Delayed institution of treatment, coupled with drug interactions 
during therapy, is linked to the high morbidity and mortality in this 
condition. A high index of clinical suspicion is therefore paramount 
[2,3].
Mycobacterial infection of the esophagus is a rare but serious 
condition, which can be difficult to diagnose, especially where evidence 
of extra-esophageal tuberculosis is lacking. Most previously reported 
cases are secondary to spread from infected mediastinal lymph nodes, 
or lungs [4].
We report the case of a simultaneous pancreas-kidney transplant 
recipient with secondary esophageal tuberculosis associated with 
subclinical pulmonary disease.
Case Report
A 47-year-old United Kingdom (UK) born woman of Jamaican 
ancestrywas seen in the renal transplant outpatient clinic with a 2-month 
history of odynophagia, retrosternal chest pains and 3-kilogramweight 
loss. She also had a dry cough, which had been previously investigated 
and diagnosed as gastro-esophageal reflux disease. Seven months prior 
to presentation, she had a fine needle aspiration of a painless enlarged 
right submandibular lymph node, which showed no evidence of 
malignant disease. The swelling subsequently resolved.
The patient had no history of previous tuberculosis infection and 
had no close contact withanyone diagnosed with tuberculosis. There 
was no history of smoking, alcohol or illicit drug use and there had 
been no recent foreign travel.
She had a background of insulin dependent diabetes mellitus 
since the age of ten with resulting nephropathy, peripheral neuropathy 
and retinopathy. She had been approaching end stage renal disease 
when she received a simultaneous pancreas-kidney transplant 3 years 
previously. Her induction therapy was Alemtuzumab and she was 
maintained on dual immunosuppressive therapy with tacrolimus and 
mycophenolatemofetil. Otherthan a single episode of Gram negative 
bacterial transplant pyelonephritis, she had been well with no delayed 
graft function or acute rejection episodes. The function of both kidney 
and pancreas transplants were good with a creatinine of 120 µmol/l and 
a normal glycatedhemoglobin, without the requirement for insulin. 
Other past medical history included hypertension andHerpes simplex 
virus (HSV) genital ulcers treated with aciclovir.
Clinical examination revealed mild epigastric tenderness. There 
was no lymphadenopathy, hepatosplenomegaly, oro-cutaneous lesions 
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